Literature DB >> 8651166

Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.

S Hürlimann1, K Michel, W Inauen, F Halter.   

Abstract

OBJECTIVES: Despite years of successful use of calcium-containing antacids in acid-related disease, allegations of gastric rebound following their intake has brought these agents into disrepute. By assessing intragastric acidity over the 24-h period, we evaluated whether antacids induce a clinically relevant acid rebound.
METHODS: Twelve healthy volunteers were assigned to a double-blind, placebo-controlled, triple cross-over comparison of placebo, Maalox Liquid, and a calcium-containing antacid, Rennie Liquid. The two antacids had identical neutralizing capacity. Each drug was administered at standard doses q.i.d 1 h after the main meals (at 1000, 1400, and 1900 h) and at bedtime (2300 h). Intragastric acidity was monitored by continuous ambulatory 24-h pH-metry on 3 separate days with a wash-out period of 1 wk. Special attention was given to the acidity of pre-determined postantacid time intervals during the day and night.
RESULTS: Both antacids led to a significant increase of the median 24-h pH and the median pH of the first postantacid hour, compared with placebo. Neither Rennie Liquid nor Maalox Liquid led to a drop of intragastric pH during the putative acid rebound time (2nd and 3rd postantacid hr and at night). A marginal increase in serum calcium and gastrin concentration with Rennie Liquid, and magnesium concentration with Maalox Liquid, were observed.
CONCLUSIONS: No gastric acid rebound was detected with the calcium carbonate-containing antacid, Rennie Liquid, or with Maalox Liquid at standard doses. An identical increase of intragastric pH was achieved with Rennie Liquid and Maalox Liquid during the first postantacid hour and the entire 24-h period.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651166

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

1.  Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.

Authors:  Richa Chandra; Ping Liu; Jeanne D Breen; Jeannine Fisher; Charles Xie; Robert LaBadie; Rebecca J Benner; Lisa J Benincosa; Amarnath Sharma
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Absence of rebound effect with calcium carbonate.

Authors:  G Simoneau
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Oct-Dec       Impact factor: 2.441

3.  Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.

Authors:  Michael P Chu; J Randolph Hecht; Dennis Slamon; Zev A Wainberg; Yung-Jue Bang; Paulo M Hoff; Alberto Sobrero; Shukui Qin; Karen Afenjar; Vincent Houe; Karen King; Sheryl Koski; Karen Mulder; Julie Price Hiller; Andrew Scarfe; Jennifer Spratlin; Yingjie J Huang; Saba Khan-Wasti; Neil Chua; Michael B Sawyer
Journal:  JAMA Oncol       Date:  2017-06-01       Impact factor: 31.777

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.